Congressman Cohen Works to Lower Prescription Drug Costs

April 30, 2019
Press Release
Judiciary Committee passes bipartisan measures


WASHINGTON – Congressman Steve Cohen (TN-09) supported four bipartisan, commonsense measures to lower prescription drug costs by easing access to generic drugs and ensuring generic drug companies can compete with the huge brand-name companies.

Congressman Cohen made the following statement:

“Americans pay far too much for prescription drugs when cheaper and equally effective generics should be available to consumers. It’s time to end our country’s distinction of spending more on prescription drugs than any other country because big companies can use anti-competitive practices to prevent generic alternatives from entering the market. These changes are long-overdue, and this legislation will help give Americans greater access to life-saving medications.”

The bills are:

  • H.R. 2375, the Preserve Access to Affordable Generics and Biosimilars Act;
  • H.R. 2374, the Stop STALLING Act;
  • H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; and
  • H.R. 2376, the Prescription Pricing for the People Act.